ClearPoint Neuro (CLPT) Depreciation and Depletion (2018 - 2019)

ClearPoint Neuro's (CLPT) quarterly Depreciation and Depletion came in at $35710.0 in Q3 2019, up 38.48% year-on-year from $25788.0 in Q3 2018, and up 2.15% quarter-over-quarter from $34960.0 in Q2 2019.

ClearPoint Neuro (CLPT) Depreciation and Depletion (2018 - 2019) Analysis & Trends

ClearPoint Neuro has disclosed Depreciation and Depletion across 2 years of filings, most recently posting $35710.0 for Q3 2019.

  • Depreciation and Depletion for Q3 2019 came in at $35710.0, up 38.48% year-over-year; the trailing twelve-month figure through Sep 2019 was $131098.0 (changed N/A YoY), and the FY2025 annual result was $400000.0, up 100.0% from the prior year.
  • Depreciation and Depletion came in at $35710.0 for Q3 2019 at ClearPoint Neuro, up from $34960.0 in the prior quarter.
  • In the past five years, Depreciation and Depletion ranged from a high of $35710.0 in Q3 2019 to a low of $23795.0 in Q2 2018.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Depreciation and Depletion (Qtr)
1 Abbott Laboratories 154.42 Bn 147.76 Bn 6.27 Bn 381.00 Mn
2 Stryker 118.12 Bn 115.25 Bn 3.81 Bn 120.00 Mn
3 Medtronic 101.72 Bn 93.55 Bn 5.76 Bn 308.00 Mn
4 Boston Scientific 67.19 Bn 65.98 Bn 3.61 Bn 29.00 Mn
5 Edwards Lifesciences 50.69 Bn 47.02 Bn 1.29 Bn -
6 Koninklijke Philips 29.38 Bn 26.07 Bn 2.07 Bn -
7 Dexcom 28.09 Bn 26.97 Bn 750.30 Mn -
8 GE HealthCare Technologies 28.08 Bn 26.02 Bn 1.98 Bn 78.00 Mn
9 Steris 19.80 Bn 19.37 Bn 697.10 Mn -
10 ClearPoint Neuro 524.46 Mn 488.86 Mn 7.76 Mn -

Historic Data

Download Data
DateValue
Sep 30, 2019 35,710.00
Sep 30, 2019 35,710.00
Jun 30, 2019 34,960.00
Jun 30, 2019 34,960.00
Mar 31, 2019 34,640.00
Mar 31, 2019 34,640.00
Sep 30, 2018 25,788.00
Sep 30, 2018 25,788.00
Jun 30, 2018 23,795.00
Jun 30, 2018 23,795.00
Mar 31, 2018 31,623.00
Mar 31, 2018 31,623.00